| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 130,972 | 135,861 | 117,648 | 121,151 | | Cost of Revenue | 83,914 | 90,646 | 78,528 | 85,480 | | | Gross Profit | 47,058 | 45,215 | 39,120 | 35,671 | | | Operating Expenses | | Research Development |
-
|
-
| 355 |
-
| | Selling General and Administrative | 14,818 | 16,288 | 17,173 | 13,934 | | Non Recurring |
-
|
-
| 56,839 | 2,803 | | Others | 18,346 | 19,530 | 16,669 | 17,033 | | | | Total Operating Expenses |
-
|
-
| 91,036 |
-
| | | | Operating Income or Loss | 13,894 | 9,397 | (51,916) | 1,901 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,493 | (1,652) | 526 | 2,748 | | Earnings Before Interest And Taxes | 14,009 | 7,745 | (51,636) | 2,738 | | Interest Expense | 15,005 | 9,846 | 9,500 | 9,773 | | Income Before Tax | (996) | (2,101) | (61,136) | (7,035) | | Income Tax Expense | 555 | 677 | 7,314 | (3,218) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,551) | (2,778) | (68,450) | (3,817) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,551) | (2,778) | (68,450) | (3,817) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,551) | ($2,778) | ($68,450) | ($3,817) |
|
0.49% Nasdaq 
Income Statement
